Companies: 10,795·Total market cap: $144.5T
InflaRx N.V.

InflaRx N.V.

IFRXNASDAQHealthcare● Active
$1.71
$-0.13(-7.07%)
Market Cap$123519376
P/E Ratio
52W High$2.949
52W Low$0.741
Overview

InflaRx N.V. (IFRX) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · IFRX · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.03M$0.17M$0.06M$0.00M$0.00M
Cost of Revenue$7.27M$3.32M$0.53M$0.00M$0.00M
Gross Profit($7.24M)($3.15M)($0.47M)$0.00M$0.00M
Gross Margin %(computed)-743.67%
Operating Expenses
R&D Expenses$25.72M$35.36M$41.02M$37.53M$35.70M
G&A Expenses$15.52M$15.29M$14.22M$14.34M$11.43M
Total Operating Expenses$41.02M$49.75M$44.13M$32.24M$47.63M
Operating Income($48.26M)($52.91M)($44.59M)($32.24M)($47.63M)
Operating Margin %(computed)
Interest Income$1.77M$3.20M$3.80M$0.61M$0.11M
Interest Expense$0.04M$0.02M$0.04M$0.05M$0.02M
Income Before Tax($45.62M)($46.06M)($42.67M)($29.48M)($45.63M)
Income Tax Expense$0.01M$0.01M$0.00M$0.00M$0.00M
Net Income($45.63M)($46.06M)($42.67M)($29.48M)($45.63M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-0.66$-0.78$-0.78$-0.61$-1.10
Wtd Avg Shares67.29M58.92M54.94M44.21M41.63M
EBITDA($45.16M)($45.55M)($42.06M)($28.84M)($44.94M)
EBITDA Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · M

Explore more InflaRx N.V. data

About InflaRx N.V. (IFRX) Income Statement

InflaRx N.V. (IFRX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, IFRX reported revenue of $0.00B, gross profit of ($0.01B) (gross margin -24677.94%), and net income of ($0.05B) — a net profit margin of -155582.08%.

Frequently asked questions

IFRX · 4 questions

InflaRx N.V. (IFRX) reported revenue of $0.00B for 2025, down 82.3% year-over-year.

IFRX revenueIFRX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09